Nabla Secures $70M in Series C Funding to Enhance AI for Healthcare Workflows
Nabla, a recognized leader in AI solutions for clinical care, has successfully raised $70 million in its Series C funding round, bringing its total funding to an impressive $120 million. This funding, led by HV Capital and supported by Highland Europe and other prominent investors, aims to drive significant advancements in healthcare through enhanced AI capabilities.
The objective of Nabla is clear: to enhance the human connection in healthcare by offering cutting-edge AI solutions capable of optimizing clinical and financial processes. Already trusted by over 130 healthcare organizations and 85,000 clinicians across the United States, Nabla’s AI assistant is rapidly establishing itself as an integral part of clinical workflows.
With the newly acquired funds, the company intends to accelerate its product development and expand its workforce in technical, clinical, and marketing sectors. This expansion will not only improve existing services but also pave the way for strategic partnerships, enabling Nabla to increase its footprint across new healthcare environments.
The past year has seen a remarkable rise in the adoption of Nabla's AI assistant, with its implementation stretching into areas such as ambulatory care, behavioral health, pediatric units, and emergency services. Already in the works are plans to incorporate Nabla’s technology into inpatient and nursing workflows, indicating a broadening scope that reflects its ambition to support various clinical roles.
This next phase of development will focus on creating a more agentic AI system, one that enhances clinical documentation integrity and can autonomously handle EHR (Electronic Health Record) commands. By merging ambient listening, dictation, and coding into a singular, extensible platform, Nabla aims to offer an intelligent assistant that intuitively streamlines existing workflows, thus allowing clinicians to devote more time to patient care.
"Nabla is committed to pushing the boundaries of what AI can achieve in the healthcare sector," says Alex Lebrun, co-founder and CEO. "Our assistant not only captures essential data but has the potential to increase efficiency by executing complex tasks within clinical environments. Our goal is for AI to become a proactive partner in patient care, rather than just a passive tool for documentation."
The AI’s trusted speed and accuracy are already yielding substantial results. Studies show that adoption of Nabla’s AI has led to a drastic reduction in documentation time by over 50%, while simultaneously alleviating clinician burnout and enhancing patient satisfaction. Moreover, the financial growth of Nabla is notable, with revenue increasing fivefold in the past six months alone.
Serving a diverse range of healthcare settings, Nabla's AI is equipped to function seamlessly in over 35 languages, thus catering to various communities, including rural healthcare systems and specialized children’s hospitals. Its capacity to integrate with major EHR platforms such as Epic, Cerner, and athenahealth showcases its versatility and commitment to addressing the pressing needs of healthcare providers.
Recognizing the importance of responsible AI use, Nabla actively participates in the Coalition for Health AI, contributing to the establishment of thoughtful governance within clinical care. The AI assistant operates on a domain-specific large language model that harnesses clinically driven data refined over the years, enabling a high degree of customization while maintaining accuracy and reliability.
Looking ahead, Nabla plans to develop advanced capabilities such as a Proactive Coding Agent for real-time coding support and a Context-Aware Agent for smarter documentation and order initiation, both aimed at elevating clinical efficiency.
As Alexander Joel-Carbonell, Partner at HV Capital noted, "Nabla stands as a trailblazer in the clinical AI arena, thanks to its remarkable speed and accuracy along with a product tailored for enterprise needs. The rapid adoption of Nabla across major healthcare organizations is a testament to their agile approach and commitment to improving clinician experiences."
Nabla continues to play a crucial role in shaping the future of healthcare by harnessing artificial intelligence to create solutions that prioritize the clinician's journey and enhance patient care. As they continue to innovate, healthcare systems and professionals can look forward to a future where intelligent assistance becomes a standard in delivering high-quality medical service, thereby restoring humanity to the complex world of healthcare.
For more information, visit Nabla's official website.
The objective of Nabla is clear: to enhance the human connection in healthcare by offering cutting-edge AI solutions capable of optimizing clinical and financial processes. Already trusted by over 130 healthcare organizations and 85,000 clinicians across the United States, Nabla’s AI assistant is rapidly establishing itself as an integral part of clinical workflows.
With the newly acquired funds, the company intends to accelerate its product development and expand its workforce in technical, clinical, and marketing sectors. This expansion will not only improve existing services but also pave the way for strategic partnerships, enabling Nabla to increase its footprint across new healthcare environments.
The past year has seen a remarkable rise in the adoption of Nabla's AI assistant, with its implementation stretching into areas such as ambulatory care, behavioral health, pediatric units, and emergency services. Already in the works are plans to incorporate Nabla’s technology into inpatient and nursing workflows, indicating a broadening scope that reflects its ambition to support various clinical roles.
This next phase of development will focus on creating a more agentic AI system, one that enhances clinical documentation integrity and can autonomously handle EHR (Electronic Health Record) commands. By merging ambient listening, dictation, and coding into a singular, extensible platform, Nabla aims to offer an intelligent assistant that intuitively streamlines existing workflows, thus allowing clinicians to devote more time to patient care.
"Nabla is committed to pushing the boundaries of what AI can achieve in the healthcare sector," says Alex Lebrun, co-founder and CEO. "Our assistant not only captures essential data but has the potential to increase efficiency by executing complex tasks within clinical environments. Our goal is for AI to become a proactive partner in patient care, rather than just a passive tool for documentation."
The AI’s trusted speed and accuracy are already yielding substantial results. Studies show that adoption of Nabla’s AI has led to a drastic reduction in documentation time by over 50%, while simultaneously alleviating clinician burnout and enhancing patient satisfaction. Moreover, the financial growth of Nabla is notable, with revenue increasing fivefold in the past six months alone.
Serving a diverse range of healthcare settings, Nabla's AI is equipped to function seamlessly in over 35 languages, thus catering to various communities, including rural healthcare systems and specialized children’s hospitals. Its capacity to integrate with major EHR platforms such as Epic, Cerner, and athenahealth showcases its versatility and commitment to addressing the pressing needs of healthcare providers.
Recognizing the importance of responsible AI use, Nabla actively participates in the Coalition for Health AI, contributing to the establishment of thoughtful governance within clinical care. The AI assistant operates on a domain-specific large language model that harnesses clinically driven data refined over the years, enabling a high degree of customization while maintaining accuracy and reliability.
Looking ahead, Nabla plans to develop advanced capabilities such as a Proactive Coding Agent for real-time coding support and a Context-Aware Agent for smarter documentation and order initiation, both aimed at elevating clinical efficiency.
As Alexander Joel-Carbonell, Partner at HV Capital noted, "Nabla stands as a trailblazer in the clinical AI arena, thanks to its remarkable speed and accuracy along with a product tailored for enterprise needs. The rapid adoption of Nabla across major healthcare organizations is a testament to their agile approach and commitment to improving clinician experiences."
Nabla continues to play a crucial role in shaping the future of healthcare by harnessing artificial intelligence to create solutions that prioritize the clinician's journey and enhance patient care. As they continue to innovate, healthcare systems and professionals can look forward to a future where intelligent assistance becomes a standard in delivering high-quality medical service, thereby restoring humanity to the complex world of healthcare.
For more information, visit Nabla's official website.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.